Send me a link:

*Text messaging rates may apply.

 Dow Up 0.43% Nasdaq Up 0.71%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.94 Up 0.04(4.17%) 3:30PM EDT - Nasdaq Real Time Price
Prev Close:0.90
Open:0.91
Bid:0.94 x 200
Ask:0.94 x 200
1y Target Est:2.75
Beta:0.93
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:0.89 - 0.95
52wk Range:0.65 - 4.00
Volume:396,314
Avg Vol (3m):789,656
Market Cap:54.44M
P/E (ttm):N/A
EPS (ttm):-0.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCUp 4.17%54.44M
AGENUp 3.04%189.82M
DNDNDown 0.93%328.83M
STMLUp 2.75%144.46M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Jun-14) :-0.05
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback